In Brief
Using structural biology, cell biology, and electrophysiology approaches, Zhu et al. demonstrate that phosphorylation of the N-terminal repeating sequences of SAPAPs is required for the SAPAP/PSD-95 complex formation and SAPAP's synaptic targeting and maturation functions. They also developed a potent non-phosphorylated PSD-95 GK inhibitory peptide that can effectively disrupt the SAPAP/PSD-95 complex formation and thus inhibit excitatory synaptic activities.
Data and Software Availability 5YPO 5YPR

INTRODUCTION
Dendritic spines are tiny membrane protrusions from dendritic shafts, and they play critical roles in synaptic transmissions. The post-synaptic density (PSD) at the distal tip of dendritic spine heads refers to a densely packed multi-protein structure orchestrating synaptic formation and function (Carlin et al., 1980; Chen et al., 2008; Sheng and Kim, 2011) . As central signal transduction hubs at synapses, the PSDs are enriched with neurotransmitter receptors, adhesion molecules, scaffold proteins, signaling enzymes, and cytoskeletal components (Bayé s and Grant, 2009; Dieterich and Kreutz, 2016; Kim and Sheng, 2004; Sheng and Hoogenraad, 2007) . Scaffold proteins serve as bridges linking the upstream glutamate receptors (i.e., NMDA-type glutamate receptors [NMDARs] and AMPA-type glutamate receptors [AMPARs] ) with the downstream signaling complexes and cytoskeletons. Accordingly, spatial and temporal organization of scaffold protein-mediated protein complexes at the core of the PSD is pivotal for synaptic signaling and plasticity (Won et al., 2017; Zhu et al., 2016b) . Mutations of genes encoding the PSD scaffold proteins have been frequently associated with various psychiatric disorders, including autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD), intellectual disability (ID), and schizophrenia (Balan et al., 2013; Grant, 2012; Lelieveld et al., 2016; Pinto et al., 2010; Ting et al., 2012; Volk et al., 2015) .
The PSD-95 family of membrane-associated guanylate kinases (MAGUKs), including PSD-95, PSD-93, SAP102, and SAP97, are the most abundant scaffold proteins in the PSDs. PSD-95 directly binds to SAPAP (also known as DLGAP or GKAP), which in turn binds to the Shank family proteins, forming the PSD-95/SAPAP/Shank core complex of PSD Naisbitt et al., 1999; Takeuchi et al., 1997) . This core complex is thought to be critical for synaptic development and transmission. Many lines of evidence have indicated that PSD-95 MAGUKs are essential for trafficking and anchoring of synaptic glutamate receptors Elias and Nicoll, 2007; Opazo et al., 2012) . Loss of PSD-95 MAGUKs led to a reduction in the number of synapses containing glutamate receptors and defects in both AMPAR and NMDAR transmissions . Likewise, removal of SAPAP or Shank also results in the loss of AMPAR-containing synapses and weaker synaptic transmissions (Hung et al., 2008; Shin et al., 2012) .
Recent super-resolution imaging studies have revealed that major synaptic scaffold proteins, such as PSD-95 and SAPAP, form co-clustered nanodomains with glutamate receptors (e.g., AMPAR) in the PSDs (MacGillavry et al., 2013; Nair et al., 2013) . Alteration of the level of PSD-95 changes the number and area of AMPAR nanodomains and synaptic transmissions (MacGillavry and Hoogenraad, 2015; Nair et al., 2013) . Importantly, the subsynaptic co-clustering of PSD-95/AMPAR alters in response to synaptic activities (Fukata et al., 2013; MacGillavry and Hoogenraad, 2015; Zhu et al., 2016b) , though with poorly understood molecular mechanisms.
Given the fundamental roles that the PSD-95/SAPAP/Shank core complex plays in orchestrating the assembly of the PSDs as well as in regulating the dynamic changes of synaptic morphology and plasticity, it is not surprising that mutations of the genes encoding these proteins can cause severe psychiatric disorders and neurodevelopmental diseases (Grant, 2012; Marín, 2012) . For example, DLG4 (encoding PSD-95) knockout mice showed increased repetitive behaviors and abnormal social behaviors reminiscent of ASD and Williams' syndrome (Feyder et al., 2010) . Human genetic studies also indicated that DLG4 is a possible candidate gene for ID and schizophrenia (Balan et al., 2013; Lelieveld et al., 2016; Rauch et al., 2012) . Mice with genetic deletion of Sapap3 or Sapap2 exhibited increased anxiety-like and aggressive behaviors relevant to OCD and ASD (Jiang-Xie et al., 2014; Welch et al., 2007) . Increasing evidence suggests that the Sapap family genes are tightly associated with the neuropathology of ASD, OCD, and Tourette's syndrome in humans (Bienvenu et al., 2009; Crane et al., 2011; Pinto et al., 2010; Stewart et al., 2013; Z€ uchner et al., 2009 ). Mutations of Shank-encoding genes are highly penetrant in causing ASD (Peç a et al., 2011; Pinto et al., 2010; Ting et al., 2012) .
A better understanding of the molecular basis underlying the PSD-95/SAPAP/Shank complex formation can provide valuable insights into the physiological roles of the complex in synapse formation and function as well as the mechanisms of brain disorders caused by alterations of these genes. Recent biochemical and structural studies have demonstrated the exquisitely specific interaction between Shank and SAPAP (Zeng et al., 2016) . However, how the SAPAP/Shank complex is recruited to the PSDs is still rudimentarily understood. SAPAP1 was shown to bind guanylate kinase (GK) domains of PSD-95 and MAGI2, and the interactions have been mapped to several 14-amino acid repeats (referred to as GK-binding repeats [GBRs] ) at the N terminus of SAPAP1 (Hirao et al., 1998; Kim et al., 1997; Naisbitt et al., 1997) . We and others have demonstrated that the GK domain of MAGUKs functions as a phosphoprotein-binding module (Johnston et al., 2012; Zhu et al., 2011 Zhu et al., , 2014 . Moreover, phosphor-SAPAP1 GBR peptides have been shown to bind to PSD-95 SH3-GK (Zhu et al., 2011) , suggesting that the PSD-95/SAPAP interaction may be regulated by phosphorylation. However, the molecular mechanism governing the phosphorylation-dependent PSD-95/SAPAP interaction has not been elucidated.
In this work, we solved the crystal structure of PSD-95 GK in complex with a synthetic phosphor-SAPAP1 GBR peptide (i.e., pSAPAP1-R2). The complex structure not only elucidates the molecular basis underlying the specific and likely synaptic activity-regulated PSD-95/SAPAP interaction but also provides a mechanistic explanation for the etiology of ID caused by a mutation identified in PSD-95. We further demonstrated that the phosphorylation-dependent PSD-95/SAPAP interaction is crucial for SAPAP synaptic targeting and SAPAP-mediated synaptogenesis. We successfully designed several non-phosphorylated GK inhibitory peptides, and we solved the structure of PSD-95 SH3-GK in complex with one of the GK inhibitory peptides. We went on to demonstrate that the most potent GK inhibitory peptide can effectively block the PSD-95/SAPAP interaction and impair synaptogenesis when expressed in cultured neurons.
RESULTS
Crystal Structure of PSD-95 GK in Complex with a Phosphorylated SAPAP1 Peptide Analysis of the GBR sequences in the SAPAP family of proteins (SAPAP1-4) reveals a highly consensus motif of -R-x-x-S-Y-xx-A-, where ''x'' denotes any residue ( Figure 1A ). We previously demonstrated that two phosphorylated SAPAP1 GBRs bind to PSD-95 SH3-GK in a fluorescence polarization-based assay (Zhu et al., 2011) . Here we first confirmed the PSD-95 GK/ SAPAP interaction using purified recombinant PSD-95 GK and two synthetic phosphor-SAPAP peptides (i.e., phosphor-SA-PAP1-GBR2 [pSAPAP1-R2] and phosphor-SAPAP3-GBR1 [pSAPAP3-R1]). Isothermal titration calorimetry (ITC)-based assays showed that PSD-95 GK binds to pSAPAP1-R2 and pSAPAP3-R1 with K d values of $0.08 and 0.07 mM, respectively ( Figure 1B ). As expected, the unphosphorylated SAPAP peptides (i.e., SAPAP1-R2 and SAPAP3-R1) displayed no detectable binding to PSD-95 GK ( Figure 1B) . Given that the sequences of GBR motifs in SAPAPs are extremely conserved, it is expected that all of the phosphor-SAPAP-GBRs can bind to PSD-95 GK with high affinity and dephosphorylation of Ser(0) in each GBR would eliminate its binding to PSD-95.
To better understand the molecular details of the PSD-95 GK/phosphor-SAPAP interaction, we solved the complex structure of PSD-95 GK/pSAPAP1-R2 at 2.3-Å resolution (Table S1 ). Each asymmetric unit contains two copies of the complex with very similar conformation. In the complex, PSD-95 GK adopts a typical GK domain architecture, and the pSAPAP1-R2 peptide forms a short helix engaging the canonical phosphopeptide-binding pocket of PSD-95 GK (Zhu et al., 2016b) (Figure 1C ). Including this study, four crystal structures of DLG GK/phosphopeptide complexes (i.e., SAP97 SH3-GK/pLGN [Zhu et al., 2011] , PSD-95 GK/pLgl2 (two structures with distinct pLgl2 peptides) [Zhu et al., 2014] , and PSD-95/pSAPAP1-R2 in this study) have been determined. Superposition of these structures reveals several common features of the DLG GK/phosphopeptide interactions ( Figure 1D ): each bound phosphopeptide contains a short a helix in its N-terminal half; DLG GK recognizes diverse phosphopeptides via similar binding sites formed by the GMPbinding (GMP-BD) and the CORE/LID subdomains; peptide binding does not induce large conformational changes to the DLG GK domains. The PSD-95 GK/pSAPAP1-R2 Interface The complex structure reveals that the pSAPAP1-R2-binding site on GK consists of two key elements: the phosphor-site and the hydrophobic site. The phosphate group of the pSAPAP1-R2 is coordinated by side chains of R568, R571, and Y580 at the phosphor-site. These polar interactions are further strengthened by intramolecular interactions between side chains of R568, E574, and Y609 of GK ( Figure 2A ). As expected, alterations of the phosphor-site of GK (the R568, R571, Y580, and Y609A quadruple mutant) totally disrupted the GK/pSAPAP1-R2 interaction ( Figure 2C ; Table S2 ). Substitution of pSer of pSAPAP1-R2 and pSAPAP3-R1 with Ala abolished the GK/pSAPAP1-R2 and GK/pSAPAP3-R1 interactions ( Figure 2C) . Surprisingly, substitution of pSer of pSAPAP1-R2 and pSAPAP3-R1 with Glu also disrupted the interactions ( Figure 2C ), suggesting that the Ser-to-Glu substitution in SAPAP GBRs cannot be used as a phosphor-mimetic mutation for investigating the PSD-95/SA-PAP interaction. This is distinct from our previous finding that the phosphor-mimetic mutant of LGN could still retain modest binding to DLG GK (Zhu et al., 2011) .
The hydrophobic site of GK is occupied by the short a helix formed by pS(0) to T(+5) of pSAPAP1-R2 (Figures 2A and 2B) . The side chains of Y(+1) and A(+4) of pSAPAP1-R2 insert into the hydrophobic pocket formed by Y580, Y604, and Y609 from GK ( Figure 2B ). In addition to forming the hydrophobic interactions with the hydrophobic site of GK, the side chain of Y(+1) of pSAPAP1-R2 forms hydrogen bonds with the side chains of E600 and T611 of GK. This is a unique feature of the GK/pSAPAP interaction compared to other GK/target interactions (Zhu et al., 2011 (Zhu et al., , 2014 (Zhu et al., , 2016a . In line with the critical roles of Y(+1) and A(+4) of pSAPAP1-R2 in the complex formation, substitutions of either Y(+1) with Ala or A(+4) with Gln eliminated the GK/ pSAPAP1-R2 interaction ( Figure 2C ). Importantly, substitution of either T611 or E600 from GK with Ala also significantly weakened its binding to pSAPAP1-R2 ( Figure 2C ), supporting the specific role of the hydrogen bonds between these two residues and the hydroxyl group of Y(+1) observed in the complex structure ( Figure 2A ; also see Figure 6 discussing a PSD-95 mutation found in ID patients).
Besides the residues involved in the two major interaction sites discussed above, several polar interactions further contribute to the specific GK/pSAPAP1-R2 interaction. For example, the side chain of R(-3) of pSAPAP1-R2 forms charge-charge interactions with the side chains of D545 and D629 of GK. The side chain of R(-2) of pSAPAP1-R2 forms hydrogen bonds with the main chains of R578 and D579 from GK. Fitting the structural analysis, substitution of R(À3) with Ala weakened the binding of pSAPAP1-R2 to GK by $3.5-fold ( Figure 2C ).
We then tested the phosphorylation-dependent interaction between the full-length PSD-95 and the full-length SAPAP expressed in heterologous cells. We used the FLAG-tagged wild-type (WT) SAPAP3 or its mutants for co-immunoprecipitation (coIP) of GFP-tagged PSD-95. SAPAP3 contains two GBR motifs ( Figure 1A ). We verified that the SAPAP3-R1 peptide binds to PSD-95 GK also in a strict phosphorylation-dependent manner. Substitution of pSer (0) with Ala or Glu also eliminated the binding of pSAPAP3-R1 to PSD-95 (bottom four rows in the right column of Figure 2C ). As expected, SAPAP3 WT showed a robust binding to PSD-95 in the coIP assay (Figure 2D ). Both the phosphor-deficient mutant (S394, 500A, referred to as S2A) and the phosphor-mimetic mutant (S394, 500E, referred to as S2E) of SAPAP3 showed significantly weaker binding to PSD-95 ( Figure 2D ). Our data are consistent with a report showing that both the phosphor-deficient mutant (S54, 201A double mutant) and phosphor-mimetic mutant (S54, 201D double mutant) of SAPAP1 displayed diminished bindings to PSD-95 GK in yeast two-hybrid assays (Shin et al., 2012) . Taken together, we concluded that phosphorylation of GBR motifs in SAPAP is critical for the PSD-95/SAPAP interaction and the S/E substitutions in the SAPAP GBRs cannot be used to mimic phosphorylation-induced binding of SAPAP to PSD-95. Phosphorylation-Dependent PSD-95/SAPAP Interaction Is Critical for SAPAP Synaptic Targeting and Dendritic Spine Development Since PSD-95 and SAPAP colocalize with each other along dendritic spines in cultured hippocampal neurons Shin et al., 2012) , we next investigated whether the phosphorylation-dependent PSD-95/SAPAP interaction is required for the synaptic targeting of SAPAP. The GFP-tagged SAPAP3 WT and its two PSD-95 binding-deficient mutants, S2A and S2E, were individually co-transfected with mCherry in cultured hippocampal neurons at day in vitro 14 (DIV14). Neurons were fixed for further imaging analysis at DIV17. As expected, the expressed GFP-SAPAP3 WT showed prominent spine localization, whereas both the S2A and S2E mutants of SAPAP3 were less enriched in spines and more diffused to dendritic shafts ( Figure 3A ). Quantitative synaptic enrichment ratio data (normalized by mCherry intensity) further confirmed that the synaptic targeting efficiency of the SAPAP3 S2A mutant was significantly lower than SAPAP3 WT (Figures 3B and 3C ; WT = 2.45 ± 0.15 and S2A = 1.88 ± 0.09; **p < 0.01, one-way ANOVA with Tukey's multiple comparison test). Notably, SAPAP3 S2E exhibited targeting deficiency very similar to that of SAPAP3 S2A (Figures 3B and 3C ; S2E = 1.89 ± 0.09). In line with this observation, in COS-7 cells, the S2D mutant (S54, 201D double mutant) of SAPAP1 did not cocluster with PSD-95, whereas SAPAP1 WT and PSD-95 formed perfect co-clustering Romorini et al., 2004; Shin et al., 2012) . Collectively, these data indicate that the phosphorylation-dependent interaction between PSD-95 and SAPAPs is critical for synaptic targeting of SAPAPs.
Dendritic spines undergo dramatic morphological changes during development. In mature neurons, the shapes of spines dynamically change in response to diverse neuronal stimuli, an activity that is tightly associated with various forms of synaptic plasticity. Given that a set of key scaffold proteins (e.g., PSD-95, SAPAP, Shank, Homer, etc.) plays essential roles in synaptic development Sala et al., 2001; Zeng et al., 2016) , we next evaluated the role of the specific PSD-95/SAPAP interaction in synaptogenesis. In this assay, we classified the spines with a mushroom-like head as mature spines (featuring largerdiameter spine heads), while others, including filopodia-like, stubby, branchy, and thin mushroom, we classified as immature spines. FLAG-tagged SAPAP3 constructs (WT, S2A, and S2E) were transfected into cultured hippocampal neurons (DIV14), and GFP was co-transfected with each SAPAP3 construct to outline the morphology of dendritic spines and as the background transfection control ( Figure 4A ). Compared to the GFP or SAPAP3 WT group, neurons overexpressing SAPAP S2A or S2E showed more filopodia-like and less mushroom-like spines at DIV17 ( Figure 4A ). Quantifications of the images revealed that overexpression of either SAPAP3 S2A or SAPAP3 S2E led to a significant reduction in the proportion of mature spines compared to the control neurons (i.e., the GFP-alone group or the SAPAP3 WT group) ( Figure 4B ; GFP = 0.33 ± 0.02, WT = 0.39 ± 0.03, S2A = 0.15 ± 0.02, and S2E = 0.18 ± 0.02; ***p < 0.001 and ****p < 0.0001, one-way ANOVA with Tukey's multiple comparison test). We also quantified the effect of PSD-95/SAPAP3 interaction on spine morphology by measuring the spine head width using ImageJ software (Zeng et al., 2016) . Neurons expressing SAPAP3 WT showed a mild but significant increase of spine head width compared to the control neurons expressing GFP only ( Figures 4C and 4D ). In contrast, neurons expressing either SAPAP3 S2A or SAPAP3 S2E showed a prominent reduction in spine head width, which is consistent with above mature spine ratio analysis (Figures 4C and 4D ; GFP = 0.52 ± 0.01 mm, WT = 0.59 ± 0.03 mm, S2A = 0.41 ± 0.01 mm, and S2E = 0.35 ± 0.01 mm; *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, one-way ANOVA with Tukey's multiple comparison test). The above data indicate that the phosphorylationdependent interaction between PSD-95 and SAPAP is crucial for dendritic spine development. Expression of the SAPAP3 S2A or SAPAP3 S2E mutants appears to have a dominant-negative effect on dendritic spine development in cultured neurons.
Disruption of the PSD-95/SAPAP Interaction by a Designed Non-phosphor Inhibitory Peptide
We next tried to evaluate the possible impact of disruption of the PSD-95/SAPAP interaction on synaptogenesis. Although the above-characterized phosphor-SAPAP peptides can be used to effectively block the PSD-95/SAPAP complex formation in vitro, they may not be effective tools for in vivo studies in neurons due to their poor cell penetration (Dunican and Doherty, 2001; Ye et al., 2007) and susceptibility of the phosphate group to removal by protein phosphatases in the cellular milieu. Another limitation of these phosphopeptides is that they cannot be genetically encoded for cellular or in vivo expressions. Furthermore, the phosphor-mimetic mutations of the SAPAP peptides are not effective in disrupting the PSD-95/SAPAP interaction either ( Figure 2C ). Therefore, we attempted to use the structural knowledge of the DLG GK/phosphopeptide interactions to design non-phosphopeptides that are capable of disrupting the PSD-95/SAPAP interaction.
Based on the sequence analysis of the DLG GK-binding phosphopeptides and the four DLG GK/phosphopeptide complex structures, the peptide-binding interface on GK can be arbitrarily separated into the following 7 sites (Xia et al., 2017; Zhu et al., 2011 Zhu et al., , 2014 Zhu et al., , 2016b ; this study) ( Figure 5A ): (1) pSer site, which coordinates the phosphate group of phosphopeptides or the side chain of pSer-mimicking Glu/Asp of non-phosphopeptides; (2) the hydrophobic site formed by P564, Y580, Y604, and Y609 of GK, which accommodates Y(+1)/A(+4) pSAPAP1-R2 , M(+1)/ L(+4) pLGN , and L(+1)/S(+4) pLgl2 , respectively; (3) the hydrophobic cradle formed by I593, A601, and L608 of GK, which coordinates M(+7) pLGN or F(+9) pLgl2 ; (4) an Asp residue cluster (D545, D549, and D629 of GK) coordinating with R(À3) pSAPAP1-R2 or K(+1) pLgl2 ; (5) the main chains of R578 and D579 of GK, which form hydrogen bonds with R(À2) pLGN or R(À2) pSAPAP1-R2 ; (6) a hydrophobic pocket formed by L552 and I627 of GK; and (7) the positively charged R637 beneath the hydrophobic cradle of GK. It is noted that the pLGN and pLgl2 peptides utilize interactions between their C-terminal tails (i.e., residues beyond the +5 position) and site 3 of GK to enhance their bindings to GK (Zhu et al., 2011 (Zhu et al., , 2014 , and such interactions do not exist in the PSD-95/pSAPAP complex (Figures 2A and 2B) . Thus, we reasoned that a chimeric phosphomimicking peptide that fuses the optimal SAPAP peptide with the C-terminal tails of the LGN peptide or Lgl2 peptide would enhance the chimeric SAPAP peptide's binding to PSD-95 GK. (G) Quantification of spine head width for neurons overexpressing designed GFP-fused peptides. Twelve neurons (i.e., n = 12) from four independent batches of cultures were imaged for each group for quantifications. Error bar indicates ± SEM. ****p < 0.0001; NS, not significant, using one-way ANOVA with Tukey's multiple comparison test.
(legend continued on next page)
Accordingly, the following three chimeric phosphomimicking GK inhibitory peptides (referred to as GKIs) were designed: QSF, RIRREEYRRANGQSF; MKL, RIRREEYRRANGQSMKL; and DLS, RIRREEYRRANGQSFDLS ( Figure 5B ). The designing strategy was as follows: a bulky hydrophobic Ile was used to substitute A(À4) of SAPAP-R2 for targeting site 6 of GK, and an Arg was placed at the À5 position for possible favorable interaction with the negatively charged residues in site 4 of GK ( Figure 5A) ; a more bulky Ile was used to substitute T(+5) of SAPAP-R2 for better binding to the hydrophobic site (i.e., site 2) of GK; and the three different C-terminal tail sequences were designed to target the hydrophobic cradle (i.e., site 3) of GK that is not used by the pSAPAP-R2 peptide (Figure 2 ) but is engaged by the pLGN or pLgl2 peptides ( Figure 5E ). A tworesidue linker (''NG'') was used to connect the C-terminal tail with the optimal SAPAP-R2. Satisfyingly, ITC-based assays revealed that these non-phosphorylated GKI peptides bound to PSD-95 GK with K d values ranging from 0.66 to 1.86 mM (Figure 5A) . Notably, the DLS peptide bound to GK with a stronger affinity than other GKIs did, which was probably due to additional interaction between D(+11) DLS and R637 in site 7 of GK (Figure 5A) . One would expect that the phosphorylated GKIs would have even stronger binding to PSD-95 GK. Indeed, the phosphorylated DLS peptide (pDLS) bound to PSD-95 GK with a super strong binding affinity (K d $2 nM) ( Figure 5B ). Taken together, the above biochemical data indicate that the strategy we used to design specific GKIs works well.
To further rationalize the enhanced GK bindings of these GKIs, we tried to crystallize various GKIs in complex with PSD-95 GK or SH3-GK. We were able to obtain the high-diffraction-quality crystals of the PSD-95 SH3-GK/QSF peptide complex, and we solved the structure at 2.35-Å resolution (Table S1 ). In the complex, the residues from E(0) to I(+5) of the QSF peptide formed an expected a-helical structure binding to site 1 and site 2 on GK. The carboxyl group of E(0) interacted with R568, R571, and Y609 in a way similar to that of pSer ( Figures 5C and 5E ). In agreement with our design strategy, I(À4) QSF interacted with hydrophobic residues in site 6 of GK ( Figure 5D ; Figure S1A ). Somewhat surprisingly, the side chain of R(+2) QSF occupied the same position as the side chain of R(À3) pSAPAP1-R2 did by forming salt bridges with the side chains of D545 and D549 (site 4) of GK (Figures 5A and 5D ; Figure S1A ). Most notably, the side chain of F(+10) QSF coupled with the hydrophobic cradle (site 3) of GK in a manner similar to that of M(+7) pLGN or F(+9) pLgl2 in their respective complex with GK ( Figures 5A, 5D , and 5E; Figure S1A) . We believe that F(+10) plays a critical role in enhancing the binding of the QSF peptide to PSD-95 GK. In line with these structural analyses, substitution of E(0) QSF with Ala dramatically weakened its binding to PSD-95 GK; substitution of A601 in the shallow hydrophobic cradle of GK accommodating F(+10) QSF with Asp also decreased PSD-95 GK's binding to the QSF peptide by $4-fold (Figures S1B-S1D ).
We next tested whether these GKIs can block the PSD-95/ SAPAP interaction in vitro. Since the DLS peptide binds to PSD-95 GK with the strongest binding affinity, we thus chose the DLS peptide for further study. As expected, glutathione S-transferase (GST)-tagged PSD-95 GK could robustly pull down FLAG-tagged SAPAP3 expressed in heterologous cells ( Figure 5F, lane 3) . Addition of the DLS peptide in the reaction mixture significantly reduced the interaction between PSD-95 GK and SAPAP3 ( Figure 5F, lane 4) , whereas the DLS E2A mutant peptide (i.e., substituting E(0) with Ala; also see Figure S1D) had no impact on the binding ( Figure 5F , lane 5), further confirming the specificity of the DLS peptide in blocking the PSD-95/SAPAP interaction.
Given that the DLS peptide can effectively block the PSD-95/ SAPAP interaction in vitro, we next investigated whether this peptide can effectively modulate the synaptogenesis when expressed in neurons. In this assay, GFP-DLS, GFP-DLS E2A, and GFP-R1R2 (SAPAP3 fragment containing two GBR motifs) were individually co-transfected with mCherry into cultured hippocampal neurons (DIV14). mCherry alone was also transfected as a control. At DIV17, all groups of neurons were fixed and analyzed for dendritic spine morphology. Neurons expressing the DLS peptide showed a significant decrease of spine head width compared with those expressing mCherry alone, the DLS E2A peptide, or the R1R2 peptide ( Figure 5G ; Figure S2 ; mCherry = 0.48 ± 0.01 mm, DLS = 0.39 ± 0.01 mm, E2A = 0.45 ± 0.01 mm, and R1R2 = 0.45 ± 0.01 mm; ****p < 0.0001, one-way ANOVA with Tukey's multiple comparison test; R1R2 peptide: a SAPAP3 fragment containing two GBR motifs in tandem), indicating that blocking the synaptic PSD-95/SAPAP interaction can interfere with dendritic spine development in cultured neurons.
We further investigated whether the DLS peptide can effectively modulate synaptic activity. EGFP-fused DLS peptide, the GFP-fused control peptide DLS-E2A, and GFP alone were expressed in the CA1 region of the dorsal hippocampus of adult mice using Lenti-DLS-GFP, Lenti-DLS-E2A-GFP, and Lenti-GFP virus vectors, respectively ( Figure S3 ). The miniature excitatory postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents (mIPSCs) from CA1 pyramidal neurons in the hippocampal slices expressing GFP, GFP-DLS-E2A, or GFP-DLS were recorded using whole-cell patch-clamp techniques ( Figures 5H and 5I ). Both the amplitudes and frequencies of mEPSCs in neurons expressing DLS were significantly reduced compared with those expressing either GFP or the GFP-DLS-E2A control ( Figure 5I ). In contrast, the mIPSCs in neurons expressing DLS-GFP did not differ from those expressing either GFP or GFP-DSL-E2A ( Figure 5I ). These data indicate that the delivery of the DLS peptide into neurons specifically weakens the excitatory synaptic strength and acts most likely through disrupting the synaptic PSD-95/ SAPAP interaction.
(H) Representative recordings of the miniature EPSCs (mEPSCs) and miniature IPSCs (mIPSCs) from CA1 pyramidal neurons in the hippocampal slices expressing GFP, GFP-DLS-E2A, or GFP-DLS. (I) The mean amplitudes (left) and the frequencies (right) of mEPSCs and mIPSCs are shown in bar graphs. Data are presented as mean ± SEM using Student's t test. (n = 9 recordings/4 mice/group; ***p < 0.001 and ****p < 0.0001).
Mechanistic Insights into an ID-Associated Mutation in PSD-95 GK PSD-95 has been associated with a variety of brain disorders, including ID, schizophrenia, and ASD (Balan et al., 2013; Feyder et al., 2010; Lelieveld et al., 2016; Nithianantharajah et al., 2013) . We noted with interest that a missense mutation of PSD-95 (T611I) was identified by a large-scale exome sequencing of patients with ID (Rauch et al., 2012) . Sequence alignment analysis showed that T611 was absolutely conserved among the DLG family of MAGUKs ( Figure 6A ). On the basis of the PSD-95 GK/pSAPAP1-R2 complex structure solved in this study, T611 locates in the binding interface between GK and pSAPAP, and the side chain of T611 forms a hydrogen bond with Y(+1) of pSAPAP1-R2 ( Figure 6B ). Therefore, substitution of T611 with Ile was expected to affect the PSD-95/pSAPAP interaction. Indeed, the T611I mutant of PSD-95 GK showed an $12-fold decrease of binding to pSAPAP1-R2 ( Figure 6C; Figure 2C) . CoIP assay also demonstrated that T611I mutation significantly decreased the interaction between the full-length PSD-95 and the full-length SAPAP3 ( Figure 6D ). Given that the tight and specific interaction between PSD-95 and SAPAPs is important for synapse development and maturation, our structural and biochemical data provide a mechanistic explanation of why the T6611I mutation of PSD-95 found in patients may interfere with synapse development and cause ID.
DISCUSSION
The PSD-95/SAPAP/Shank complex plays vital roles in synaptic development and activities by interfacing the glutamate recep- tors on the synaptic plasma membranes and actin cytoskeleton at the deeper layer of PSD. Recently, we discovered an exquisitely strong binding mode between Shank and SAPAP that determines the highly specific Shank/SAPAP complex formation as well as targeting of Shank to synapses (Zeng et al., 2016) . In the present study, we provide biochemical and structural evidence showing that the interaction between PSD-95 and SAPAP is also very strong and specific (K d in the range of a few dozens of nanomolar). Most importantly, we demonstrate that the specific interaction between PSD-95 and SAPAPs is phosphorylation dependent. Phosphorylation of a highly conserved Ser residue in each GBR motif of SAPAPs switches on the interaction between PSD-95 and SAPAPs. Removal of the phosphate group from the Ser in GBR eliminates the binding of SAPAPs to PSD-95 (Figure 1) . We also provide evidence to show that the phosphorylation-dependent PSD-95/ SAPAP interaction is required for SAPAP's synaptic targeting and dendritic spine development (Figures 3 and 4) . These findings indicate that the formation of the PSD-95/SAPAP complex in PSD is regulated by synaptic activities, providing an avenue for dynamic regulation of PSD assemblies. It is envisioned that changes of synaptic activity and ensuing alterations of protein kinase/phosphatase activity can modulate phosphorylation status of the GBR motifs in SAPAPs and, thus, regulate the formation of the PSD-95/SAPAP complex.
Our above finding immediately raises a number of questions: (1) Are SAPAPs phosphorylated in vivo and to what extent are SAPAPs phosphorylated? (2) Which kinase(s) phosphorylates SAPAPs? (3) Which phosphatase(s) acts to remove the phosphorylation? (4) How are the activities of the kinase(s) and phosphatase(s) coordinated with synaptic signals? Proteomic studies have indicated that SAPAPs are indeed phosphorylated in vivo (Collins et al., 2005; Trinidad et al., 2005 Trinidad et al., , 2008 . Moreover, the GBR motifs of SAPAPs have been shown to be phosphorylated by CaMKII directly in vitro and in cultured neurons (Collins et al., 2005; Shin et al., 2012; Trinidad et al., 2005) , thus linking the key synaptic activity regulatory kinase with the PSD-95/SAPAP complex formation. It is noted that the consensus sequence (-R-x-x-S-Y-x-x-A-) from the GBR motifs of SAPAPs fits well with the substrate recognition sequences of other kinases, including protein kinase A (PKA), protein kinase C (PKC), and protein kinase D (PKD) (Ubersax and Ferrell, 2007; Wang et al., 2012) ; it is tempting to speculate that SAPAPs might also be phosphorylated by these kinases in synapses. CaMKII, PKA, and PKC are all known to be tightly associated with synaptic development and plasticity via phosphorylating a wide spectrum of synaptic proteins (Boehm et al., 2006; Okamoto et al., 2009; Zhong et al., 2009) . Therefore, the phosphorylation-dependent PSD-95/SAPAP interaction can, in principle, provide a regulated switch of assembly/disassembly of PSD components, which is likely coupled to synaptic activity changes. Future work is required to validate whether the direct coupling between regulated PSD-95/SAPAP-mediated PSD assembly and dynamic changes in synaptic activity is indeed present in neurons and, if the answer is yes, how such coupling is modulated via synaptic activity-dependent modulations of specific kinases and phosphatases.
Mammals contain four paralogs of DLGs and four SAPAPs. The existence of multiple highly homologous paralogs of these two major PSD scaffold proteins have posed major challenges in investigating their roles in synaptic development and functions, in large part due to compensatory effects among the members. It is desirable to develop tools that can specifically modulate the interactions between the DLG family and the SAPAP family proteins for studying their functional roles in synapses under both physiological and pathological conditions. Based on the structures of DLG GK/target complexes elucidated in this work and our earlier studies, we successfully designed a non-phosphopeptide that can specifically inhibit the formation of the PSD-95/SAPAP complex ( Figure 5A ). Given that the GK domains of DLGs share essentially the same phosphopeptide-binding property (Zhu et al., 2011 (Zhu et al., , 2014 and the SAPAPs contain highly conserved GBR motifs, our developed GKI is expected to be able to block the complex formation between all paralogs of the DLG family and the SAPAP family proteins. Our developed GKI does not require Ser(0) in GBR motifs to be phosphorylated, and thus it should be more stable when delivered to living neurons. Perhaps most importantly, such non-phosphopeptide can be genetically encoded and paired with any tagging sequences, such as fluorescence proteins or specific cellular targeting motifs, for various cell biology studies of the functions of the DLG/SAPAP interactions. We have provided a proof-ofconcept use of such inhibitory peptide by studying their impact on the synaptic targeting of SAPAPs and synaptogenesis and synaptic activity using neuronal culture as well as brain slice culture as the models ( Figure 5 ). We note that the binding affinity of the best GKI (the DLS peptide; Figure 5 ), although with a K d value at a sub-micromolar range, is still about 10-fold lower than the naturally occurring phosphor-GBR motif peptides (Figures 5B and 2C) . Further work is required to develop GKIs with even higher binding affinities to the DLG GK domains.
Finally, the structure of the PSD-95 GK/pSAPAP1-R2 complex determined in this study, together with our systematic biochemical investigations, not only elucidates the mechanistic basis governing the phosphorylation-dependent PSD-95/SAPAP complex formation but also provides a foundation for understanding why certain mutations of the genes encoding the two major scaffold proteins may cause neuronal diseases in humans.
EXPERIMENTAL PROCEDURES Protein Expression and Purification
Preparations of the rat PSD-95 GK domain (amino acid residues 531-713; NCBI sequence: NP_062567) and various mutants followed the previously described methods (Zhu et al., 2011 (Zhu et al., , 2014 . All the phosphor-or non-phosphor-SAPAP peptides and the GKIs were commercially synthesized (China Peptides).
ITC Assay
ITC measurements were performed on a MicroCal iTC200 system (Malvern) in a buffer containing 50 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, and 1 mM DTT at 25 C. The concentrations of proteins loaded into the syringe and the cell were 0.5 and 0.05 mM, respectively. The titration data were analyzed using Origin7.0 from MicalCal and fitted by a one-site binding model. The error on each K d value represents the SE for the fit of the curve from each titration experiment. The summary of parameters of ITC assays in this study are listed in Table S2 .
Protein Crystallization and Structure Determination
Crystals of the PSD-95 GK/pSAPAP1-R2 complex and the PSD-95 SH3-GK/ GKI-QSF complex were obtained by the hanging drop vapor diffusion method at 16 C. The PSD-95 GK/pSAPAP1-R2 complex crystals were grown in 0.1 M ammonium acetate, 0.1 M Bis-Tris (pH 5.5), and 17% w/v polyethylene glycol 10,000. The PSD-95 SH3-GK/GKI-QSF complex crystals were grown in 0.1 M Tris (pH 8.0) and 35% tert-butanol; 25% glycerol was added as the cryo-protectant before diffraction data collection. The structures were both solved by the molecular replacement method using PSD-95 SH3-GK structure (PDB: 1KJW) as the search model with Phaser (McCoy et al., 2007) in CCP4 (Murshudov et al., 2011) . Refinements were carried out using phenix.refinement (Adams et al., 2010) . The pSAPAP-R2 peptides and the GKI-QSF peptide were manually built. Further model buildings and adjustment were completed using Coot (Emsley et al., 2010) . The structural diagrams were prepared by the program PyMOL (www.pymol.org).
CoIP Assay and GST Pull-Down Assay For coIP assays, FLAG-tagged SAPAP3 and GFP-tagged PSD-95 and their various mutants were co-expressed in HEK293T cells. After 24 hr of transfection, cells were lysed in the ice-cold cell lysis buffer containing 50 mM HEPES (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM EGTA, 1% Triton, and protease inhibitor cocktail for 1 hr at 4 C, followed by centrifugation at 12,000 rpm for 10 min at 4 C. In each reaction, the supernatant was incubated with 20 mL anti-FLAG M2 magnetic beads (Sigma-Aldrich) for 1 hr at 4 C. After extensive washing, the captured proteins were separated by SDS-PAGE and detected by western blot using specific antibodies. For the GST pull-down assay, HEK293T cells expressing the FLAG-tagged SAPAP3 were lysed in the ice-cold cell lysis buffer, followed by centrifugation at 12,000 rpm for 10 min at 4 C. The supernatant was incubated with 20 mL glutathione Sepharose beads loaded with GST-GK with or without GKIs for 2 hr at 4 C. After extensive washing, the captured proteins were separated by SDS-PAGE and detected by western blot using anti-FLAG antibody (Sigma).
Primary Hippocampal Neuron Culture
Hippocampal neuron cultures were prepared as previously described (Zeng et al., 2016) . At DIV14, neurons were transfected with 2 mg plasmids per well (12-well plate) using Lipofectamine 2000 reagent (Invitrogen). Neurons were fixed at DIV17 with 4% paraformaldehyde (PFA) together with 4% sucrose in 13PBS buffer and mounted on slides for imaging.
Image Acquisition and Quantification
Confocal images were obtained using a Leica SP8 confocal microscope with a 403 oil-immersion lens. Transfected neurons were chosen randomly for quantification from at least three independent batches of cultures. For detailed spine visualization, an additional 53 zoom factor was applied. Normally, four randomly selected dendrites ($60 mm in length each) were imaged and analyzed from an individual neuron. Each image was collected as a z series maxim projection with 0.35-mm depth intervals. Intensity and spine head width were measured with ImageJ.
Stereotaxic Injection
Mice (C57BL/6, 4-5 weeks old, male) were anesthetized with isoflurane (2%-5%) and then placed in a stereotaxic device where the head was fixed and the skull was exposed. Burr holes were made, and a microsyringe (World Precision Instruments) was slowly lowered into the dorsal CA1 at 2.06 mm anteroposterior, 1.38 mm mediolateral, and 1.60 mm dorsoventral relative to bregma. For the electrophysiological experiments, 200 nL virus was pressure-injected into each hemisphere. The syringe remained in place for 5 min and was then slowly retracted out. The mice were placed on a heating pad during the surgery. After virus injection, the scalp was sutured and saline was administered subcutaneously. The mice were placed on the heating pad during recovery from anesthesia. The electrophysiological experiments were conducted 2 weeks after the virus injection. Mice were bred and reared under the conditions in accordance with institutional guidelines and the Animal Care and Use Committee of the animal core facility at Huazhong University of Science and Technology, Wuhan, China.
Electrophysiology
Hippocampal slices (300 mm) were prepared as described previously (Tu et al., 2010) . The slices were transferred to a holding chamber that contains artificial cerebrospinal fluid (in mM: 124 NaCl, 3 KCl, 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 1.2 MgCl 2 , 10 C 6 H 12 O 6 , and 2 CaCl 2 [pH 7.4], 305 mOsm). The slices were allowed to recover at 31.5 C for 30 min and then at room temperature for 1 hr. Acute slices were transferred to a recording chamber continuously, which was perfused with oxygenated artificial cerebrospinal fluid (2 mL/min) and maintained at room temperature. For whole-cell patch-clamp recordings from the CA1 pyramidal cells, hippocampal slices were visualized via IR-DIC by using an Axioskop 2FS equipped with Hamamatsu C2400-07E optics (Hamamatsu City, Japan). Basic electrophysiological properties were recorded when stable recordings were achieved with good access resistance ($20 MU). The mEPSCs were recorded using an internal solution containing (in mM) 140 potassium gluconate, 10 HEPES, 0.2 EGTA, 2 MgATP, 2 NaCl, and 0.3 NaGTP and an external solution containing 10 mM bicuculline and 1 mM tetrodotoxin (TTX). The mIPSCs were recorded with an internal solution containing (in mM) 153.3 CsCl,1 MgCl 2 , 5 EGTA, 10 HEPES, 4 MgATP and an external solution containing 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 50 mM APV, and 1 mM TTX. The data were collected at 10 kHz and filtered with a low-pass filter at 2 kHz. Miniature events were analyzed in Clampfit 10.2 software (Molecular Devices, Sunnyvale, CA, USA) using template matching and a threshold of 5 pA.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the atomic coordinates of the PSD-95 GK/ pSAPAP1-R2 complex and of the PSD-95 SH3-GK/QSF complex reported in this paper are PDB: 5YPO and 5YPR, respectively.
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